Temozolomide: all 659 studies that test it
Page 4 of 7. Open to participants first (91), then studies with results posted, then the rest; newest registration first within each.
- Vincristine and Temozolomide in Combination With PEN-866 for Adolescents and Young Adults With Relapsed or Refractory Solid TumorsSuspendedNCT04890093Phase 1/2
- A Study of Toripalimab or Combining With Temozolomide（iv） in the Treatment of Advanced/Metastatic Malignant MelanomaStatus unknownNCT04884997Phase 2
- NTX-301 Monotherapy in Advanced Solid Tumours and in Combination With Platinum-based Chemotherapy in Advanced Ovarian & Bladder Cancer and in Combination With Temozolomide in High-grade GliomaTerminatedNCT04851834Phase 1/2
- Neoadjuvant Temozolomide Combined With Simultaneous IMRT for Treatment of GlioblastomaStatus unknownNCT04829097Phase 3
- Pamiparib and Low Dose Temozolomide In Patients With Platinum Sensitive Biliary Tract CancerWithdrawnNCT04796454Phase 2
- 131I-Omburtamab, in Recurrent Medulloblastoma and EpendymomaActive, not recruitingNCT04743661Phase 2
- TEMOkids Study : A Phase I Pediatric Study for KIMOZO, Oral Suspension of TemozolomideCompletedNCT04610736Phase 1
- Pamiparib and Temozolomide for the Treatment of Hereditary Leiomyomatosis and Renal Cell CancerWithdrawnNCT04603365Phase 2
- Neoadjuvant PD-1 in Newly Diagnosed GlioblastomaStatus unknownNCT04583020Phase 2
- Multiparametric MR-Guided High Dose Adaptive Radiotherapy With Concurrent Temozolomide in Patients With Newly Diagnosed GlioblastomaActive, not recruitingNCT04574856Phase 2
- A Trail of Fluzoparil in Combination With Temozolomide in Patients With Recurrent GlioblastomaStatus unknownNCT04552977Phase 2
- HSRT and IMRT Chemoradiotherapy for Newly Diagnosed GBMStatus unknownNCT04547621Phase 1/2
- Temodar Plus Tyrosine Kinase Inhibitors for Progressive CNS DiseaseCompletedNCT04541407Phase 1
- RRx-001 Given With Irinotecan and Temozolomide for Pediatric Patients With Recurrent or Progressive Malignant Solid and Central Nervous System TumorsTerminatedNCT04525014Phase 1
- Ibrutinib With Methotrexate and Temozolomide for Patients With Newly Diagnosed Primary CNS LymphomaStatus unknownNCT04514393Phase 2
- Study of Tumor Treating Fields With Hypofractionated Chemoradiotherapy in Newly Diagnosed GlioblastomaCompletedNCT04474353Phase 1
- Bioequivalence Study Between Temozolomide Oral Suspension (Ped-TMZ) and Temodal® CapsulesCompletedNCT04467346Phase 1
- Temozolomide, Cisplatin, and Nivolumab in People With Colorectal CancerCompletedNCT04457284Phase 2
- Camrelizumab Plus Apatinib and Temozolomide as First Line Therapy in Advanced Acral MelanomaStatus unknownNCT04397770Phase 2
- Partial Brain RT, Temozolomide, Chloroquine, and TTF Therapy for the Treatment of Newly Diagnosed GlioblastomaTerminatedNCT04397679Phase 1
- Open-label Study Investigating of OKN-007 Combined With Temozolomide in Patients With Recurrent GlioblastomaCompletedNCT04388475Phase 2
- Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid TumorsActive, not recruitingNCT04337177Phase 1
- A Study of CC-90010 in Combination With Temozolomide With or Without Radiation Therapy in Participants With Newly Diagnosed GlioblastomaTerminatedNCT04324840Phase 1
- Anticancer Therapeutic Vaccination Using Telomerase-derived Universal Cancer Peptides in GlioblastomaCompletedNCT04280848Phase 2
- Nivolumab in Combination With Temozolomide and Radiotherapy in Children and Adolescents With Newly Diagnosed High-grade GliomaCompletedNCT04267146Phase 1/2
- The Effect of Chemoradiotherapy in Patients With Refractory Pituitary AdenomasStatus unknownNCT04244708Phase 2/3
- 9-ING-41 in Pediatric Patients With Refractory Malignancies.TerminatedNCT04239092Phase 1
- Repurposing Chlorpromazine in the Treatment of GlioblastomaStatus unknownNCT04224441Phase 2
- NK Cells Infusions With Irinotecan, Temozolomide, and DinutuximabActive, not recruitingNCT04211675Phase 1/2
- A Study of Maprotiline in Combination With Tamoxifen and Temozolomide for Recurrent GlioblastomaWithdrawnNCT04200066Phase 1
- Temozolomide for Second-Line Treatment of Neuroendocrine CarcinomasCompletedNCT04122911Phase 2
- Evaluate the Safety and Effectiveness of Intranasal Administration of Temozolomide in Patients With GlioblastomaCompletedNCT04091503Phase 1
- Nivolumab, BMS-986205, and Radiation Therapy With or Without Temozolomide in Treating Patients With Newly Diagnosed GlioblastomaActive, not recruitingNCT04047706Phase 1
- Short Course Chemo-Radiation Therapy for Patients With Newly Diagnosed GlioblastomaActive, not recruitingNCT04019262Phase 1/2
- First-line Chemotherapy With Temozolomide Alone for Non-enhancing Adult Brainstem Gliomas, With a Diffuse Subtype and Showing Clinical and/or Radiological Infiltrative Pattern of ProgressionStatus unknownNCT03932981Phase 2
- NIVOLUMAB Plus IPILIMUMAB and TEMOZOLOMIDE in Microsatellite Stable, MGMT Silenced Metastatic Colorectal CancerCompletedNCT03832621Phase 2
- Niraparib, Temozolomide and Atezolizumab in Treating Patients With Advanced Solid Tumors and Extensive-Stage Small Cell Lung Cancer With a Complete or Partial Response to Platinum-Based First-Line ChemotherapyActive, not recruitingNCT03830918Phase 1/2
- Early Temozolomide in Patients With High-Grade Gliomas in RehabilitationWithdrawnNCT03796507Early Phase 1
- Study to Evaluate Ibudilast and TMZ Combo Treatment in Newly Diagnosed and Recurrent GlioblastomaCompletedNCT03782415Phase 1/2
- TTFields Together With Temozolomide and Radiotherapy in Patients With Newly Diagnosed GBMStatus unknownNCT03780569Not applicable
- HFSRT With Concurrent TMZ for Large BMsStatus unknownNCT03778541Phase 3
- BGB-290 and Temozolomide in Treating Isocitrate Dehydrogenase (IDH)1/2-Mutant Grade I-IV GliomasActive, not recruitingNCT03749187Phase 1
- Temozolomide Combine With Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost for Non Small Cell Lung Cancer Brain MetastasesStatus unknownNCT03732482Phase 2/3
- Nivolumab and Temozolomide in Treating Patients With Recurrent or Refractory Small-Cell Lung Cancer or Advanced Neuroendocrine CancerCompletedNCT03728361Phase 2
- A Study of the Safety and Pharmacokinetics of BRCX014 in Patients With GlioblastomaStatus unknownNCT03687034Phase 1
- Talazoparib and Low-Dose Temozolomide in Treating Participants With Relapsed or Refractory Extensive-Stage Small Cell Lung CancerActive, not recruitingNCT03672773Phase 2
- Efficacy of Two Temozolomide Regimens in Adjuvant Treatment of Patients With Brain High Grade GliomaStatus unknownNCT03633552Phase 3
- A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI MalignanciesStatus unknownNCT03607643Phase 1/2
- OKN-007 in Combination With Adjuvant Temozolomide Chemoradiotherapy for Newly Diagnosed GlioblastomaActive, not recruitingNCT03587038Phase 1
- SGT-53 in Children With Recurrent or Progressive CNS MalignanciesWithdrawnNCT03554707Early Phase 1
- Ibrutinib With Radiation and Temozolomide in Patients With Newly Diagnosed GlioblastomaCompletedNCT03535350Phase 1
- TN-TC11G (THC+CBD) Combination With Temozolomide and Radiotherapy in Patients With Newly-diagnosed GlioblastomaCompletedNCT03529448Phase 1/2
- Telaglenastat With Radiation Therapy and Temozolomide in Treating Patients With IDH-Mutated Diffuse Astrocytoma or Anaplastic AstrocytomaActive, not recruitingNCT03528642Phase 1
- Ruxolitinib With Radiation and Temozolomide for Grade III Gliomas and GlioblastomaCompletedNCT03514069Phase 1
- Pre-operative RT and TMZ in Patients With Newly Diagnosed GBM Diagnosed Glioblastoma. A Phase I Study. (PARADIGMA)WithdrawnNCT03480867Phase 1
- Temozolomide, Radiation Therapy, and Tumor Treating Fields Therapy in Treating Participants With GlioblastomaCompletedNCT03477110Early Phase 1
- Glasdegib (PF-04449913) With Temozolomide Newly Diagnosed GlioblastomaCompletedNCT03466450Phase 1/2
- Hydroxy-urea and Temozolomide in Patients With a Recurrent Malignant Brain Tumor (Glioblastoma)Status unknownNCT03463733Phase 1
- HDI Versus Chemotherapy as Systemic Adjuvant Therapy for Resected Mucosal MelanomaStatus unknownNCT03435302Phase 3
- A Longitudinal Assessment of Tumor Evolution in Patients With Brain CancerCompletedNCT03425292Phase 1
- A Study of Apatinib Combined With Temozolomide in Patients Witn Advanced MelanomaStatus unknownNCT03422445Phase 2
- Nimotuzumab Plus Radiotherapy With Concomitant and Adjuvant Temozolomide for Cerebral GlioblastomaCompletedNCT03388372Phase 2
- CAPTEM or FOLFIRI as SEcond-line Therapy in NEuroendocrine CArcinomasTerminatedNCT03387592Phase 2
- Irinotecan and Temozolomide for Ewing SarcomaStatus unknownNCT03359005Phase 2
- Two Chemotherapy Regimens Plus or Minus BevacizumabActive, not recruitingNCT03351296Phase 2
- Concomitant Association of Ultrafractionated Brain Irradiation - Temozolomide in Inoperable Primary Glioblastoma MultiformeCompletedNCT03310372Phase 2
- 5 Fraction Stereotactic Radiosurgery With Temozolomide for Glioblastoma MultiformeCompletedNCT03291990Early Phase 1
- Study to Compare Capecitabine Combined With Dacarbazine(CAPDTIC) Versus Capecitabine Combined Temozolomide(CAPTEM) in Advanced and Metastatic Gastrointestinal Pancreatic and Esophageal Neuroendocrine TumorStatus unknownNCT03279601Phase 2
- Quality of Life and Neurocognitive FunctioningCompletedNCT03257618Not applicable
- Study on Low Dose Temozolomide Plus Metformin or Placebo in Patient With Recurrent or Refractory GlioblastomaCompletedNCT03243851Phase 2
- International Cooperative Phase III Trial of the HIT-HGG Study Group (HIT-HGG-2013)Status unknownNCT03243461Phase 3
- NovoTTF-200A and Temozolomide Chemoradiation for Newly Diagnosed GlioblastomaCompletedNCT03232424Phase 1
- Phase I/IIa Study of Concomitant Radiotherapy With Olaparib and Temozolomide in Unresectable High Grade Gliomas PatientsActive, not recruitingNCT03212742Phase 1/2
- A Study of Tegafur Combined With Temozolomide Versus Tegafur Combined With Temozolomide and Thalidomide in Subjects With Advanced Pancreatic Neuroendocrine TumorStatus unknownNCT03204019Phase 2
- Study of Chemoimmunotherapy for High-Risk NeuroblastomaActive, not recruitingNCT03189706Early Phase 1
- PAZIT Study for Children and Young Adults With Relapsed or Refractory SarcomaCompletedNCT03139331Phase 1
- Study of Acetazolamide With Temozolomide in Adults With Newly Diagnosed or Recurrent Malignant GliomaActive, not recruitingNCT03011671Phase 1
- Autologous Stem Cell Collection and Reinfusion in Newly Diagnosed High Grade GliomasWithdrawnNCT02976441Early Phase 1
- Extensive Stage Sclc Patients Who Were Benefit From First-line Treatment Accept Temozolomide Maintain TherapeuticStatus unknownNCT02972320Phase 2
- Expedited Laser Interstitial Thermal Therapy + Chemoradiation For Newly Diagnosed High Grade GliomasCompletedNCT02970448Early Phase 1
- Safety of TAS-102 in Combination With Temozolomide for Metastatic Pancreatic NETsTerminatedNCT02943733Phase 1
- Temozolomide in Treatment of Patients With Primary Central Nervous System LymphomaStatus unknownNCT02934204Phase 2
- Combining Sunitinib, Temozolomide and Radiation to Treat Patients Diagnosed With GlioblastomaStatus unknownNCT02928575Phase 2
- Temozolomide Plus Bevacizumab in Supratentorial Glioblastoma in 70 Years and Older Patients With an Impaired Functional StatusCompletedNCT02898012Phase 2
- Feasibility Study on LITT for Newly Diagnosed GlioblastomaTerminatedNCT02880410Phase 1
- RRx-001 + Radiation + Temozolomide In Newly Diagnosed Glioblastoma and Anaplastic GliomasCompletedNCT02871843Phase 1
- A Clinical Trial on Whole-brain Radiotherapy With Temozolomide Concurrent Chemotherapy or Avoidance of Hippocampus for Patients of Brain MetastasesStatus unknownNCT02832635Phase 2
- Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine TumorWithdrawnNCT02831179Phase 1
- Temozolomide as Maintenance Therapy Following Induction Chemotherapy in Extensive Stage Small Cell Lung CancerStatus unknownNCT02772107Phase 2/3
- A Proof-of-concept Clinical Trial Assessing the Safety of the Coordinated Undermining of Survival Paths by 9 Repurposed Drugs Combined With Metronomic Temozolomide (CUSP9v3 Treatment Protocol) for Recurrent GlioblastomaCompletedNCT02770378Phase 1/2
- CCRT With Temozolomide Versus RT Alone in Patients With IDH Wild-type/TERT Promoter Mutation Grade II/III GliomasStatus unknownNCT02766270Early Phase 1
- Bevacizumab Alone Versus Dose-dense Temozolomide Followed by Bevacizumab for Recurrent Glioblastoma, Phase IIICompletedNCT02761070Phase 3
- Erlotinib in Combination With Temozolomide in Treating Relapsed/Recurrent/Refractory Pediatric Solid TumorsWithdrawnNCT02689336Phase 2
- Radiation Therapy and Combination Chemotherapy for MedulloblastomaStatus unknownNCT02681705Phase 2
- Trial of Hypofractionated Intensity Modulated Radiation Therapy With Temozolomide and Granulocyte-macrophage Colony-stimulating Factor for Patients With Newly Diagnosed Glioblastoma MultiformeStatus unknownNCT02663440Phase 2
- Stereotactic Radiotherapy Plus Temozolomide for Refractory Brain MetastasesCompletedNCT02654106Phase 2
- Temozolomide in Preventing Brain Metastases in Small Cell Lung CancerStatus unknownNCT02605811Phase 2
- Phase II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or GliosarcomaWithdrawnNCT02599090Phase 2
- Prospective Pilot Trial to Assess a Multimodal Molecular Targeted Therapy in Children, Adolescent and Young Adults With Relapsed or Refractory High-grade PineoblastomaCompletedNCT02596828Phase 2
- Radiation Therapy With Temozolomide and Pembrolizumab in Treating Patients With Newly Diagnosed GlioblastomaTerminatedNCT02530502Phase 1